Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$359.77 - $441.52 $29.3 Million - $36 Million
-81,555 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $22.4 Million - $29.6 Million
81,555 New
81,555 $29.6 Million
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $53.1 Million - $70.8 Million
-208,112 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $71.1 Million - $85.8 Million
-261,404 Reduced 55.68%
208,112 $67.6 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $21.8 Million - $24.8 Million
-81,048 Reduced 14.72%
469,516 $137 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $111 Million - $127 Million
-430,025 Reduced 43.85%
550,564 $162 Million
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $41.6 Million - $53.7 Million
-196,252 Reduced 16.68%
980,589 $268 Million
Q4 2018

Feb 14, 2019

SELL
$208.47 - $251.98 $215 Million - $260 Million
-1,033,101 Reduced 46.75%
1,176,841 $263 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $69.2 Million - $82.3 Million
-336,659 Reduced 13.22%
2,209,942 $539 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $84.5 Million - $91.4 Million
-416,142 Reduced 14.05%
2,546,601 $528 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $70.4 Million - $81.8 Million
-364,833 Reduced 10.96%
2,962,743 $612 Million
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $109 Million - $120 Million
598,749 Added 21.94%
3,327,576 $632 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $5.35 Million - $6.04 Million
-31,138 Reduced 1.13%
2,728,827 $516 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,759,965
2,759,965 $482 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.